Experimental inoculation of cats with human coronavirus 229E and subsequent challenge with feline infectious peritonitis virus.
AUTOR(ES)
Barlough, J E
RESUMO
Minimal-disease cats exposed to live human coronavirus 229E developed homologous antibody responses that suggested little or no replication of the virus in inoculated animals. Oronasal and subcutaneous inoculation of coronavirus 229E did not elicit an antibody response by heterologous (transmissible gastroenteritis virus, canine coronavirus) neutralization or by heterologous (transmissible gastroenteritis virus) kinetics-based enzyme-linked immunosorbent assay. No clinical signs attributable to coronavirus 229E were seen in inoculated cats. Although the number of animals in each of the five experimental groups was small (n = 2), antibodies produced in response to the virus did not appear to sensitize cats to subsequent feline infectious peritonitis virus challenge, but neither did they cross-protect cats against the challenge dose.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1236175Documentos Relacionados
- Two related strains of feline infectious peritonitis virus isolated from immunocompromised cats infected with a feline enteric coronavirus.
- Antibody to virus components in volunteers experimentally infected with human coronavirus 229E group viruses.
- Interspecies aminopeptidase-N chimeras reveal species-specific receptor recognition by canine coronavirus, feline infectious peritonitis virus, and transmissible gastroenteritis virus.
- Persistent Infection of Human Oligodendrocytic and Neuroglial Cell Lines by Human Coronavirus 229E
- Biosynthesis, purification, and characterization of the human coronavirus 229E 3C-like proteinase.
